| CAS编号 | 中文名 | 英文名 | 分子式 | 分子量 | 熔点 | 沸点 |
| 1429421-99-7 | 2,2,6,6-四甲基氧基-4-羧酸 | 2,2,6,6-tetramethyloxane-4-carboxylic acid | C10H18O3 | 186.25 | | |
| 1429422-26-3 | | 5-chloro-2,4-difluorophenylacetonitrile | C8H4ClF2N | 187.5700 | | |
| 142943-51-9 | | n-(4-amino-1,2,3,6-tetrahydro-1,3-dimethyl-2,6-dioxo-5-pyrimidinyl)-acetamid | | | | |
| 142943-95-1 | | n-[1h-1,2,3-benzotriazol-1-yl(phenyl)methyl]aniline | | | | |
| 1429436-06-5 | 3, 3'-(吡啶-3, 5-二基)二苯甲酸 | 3, 3'-(Pyridine-3, 5-diyl)dibenzoic acid | C19H13NO4 | 319.31 | | |
| 142944-05-6 | | dimethyl 2-(dimethoxybenzylidene)malonate | | | | |
| 142944-38-5 | | 1h-pyrido(3,4-b)indol-1-one, 2,3,4,9-tetrahydro-2-(3-(4-phenyl-1-piperazinyl)pr | | | | |
| 142944-39-6 | | azinyl)propyl)- | | | | |
| 142944-40-9 | | 1h-pyrido(3,4-b)indol-1-one, 2,3,4,9-tetrahydro-6-chloro-9-methyl-2-(3-(4-pheny | | | | |
| 142944-41-0 | | 1h-pyrido(3,4-b)indol-1-one, 2,3,4,9-tetrahydro-6-methoxy-9-methyl-2-(3-(4-phen | | | | |
| 142944-42-1 | | 1h-pyrido(3,4-b)indol-1-one, 2,3,4,9-tetrahydro-2-(3-(4-(2-chlorophenyl)-1-pipe | | | | |
| 142944-43-2 | | 1h-pyrido(3,4-b)indol-1-one, 2,3,4,9-tetrahydro-2-(3-(4-(3-chlorophenyl)-1-pipe | | | | |
| 142944-44-3 | | 1h-pyrido(3,4-b)indol-1-one, 2,3,4,9-tetrahydro-6-chloro-2-(3-(4-(3-chloropheny | | | | |
| 142946-79-0 | 4,4'-双(三氟甲基)-2,2'-联吡啶 | 4,4'-bis(trifluoromethyl)-2,2'-bipyridine | C12H6F6N2 | 292.18 | 80°C | |
| 142946-80-3 | 5,5'-二(三氟甲基)-2,2'-联吡啶 | 5,5'-bis(trifluoromethyl)-2,2'-bipyridine | C12H6F6N2 | 292.18 | 131°C | |
| 142947-10-2 | 三(4,4'-双(三氟甲基)-2,2'-联吡啶)钌(II) 双(六氟磷酸盐) | Tris(4,4'-Bis(trifluoromethyl)-2,2'-bipyridine)Ruthenium(II) bis(hexafluorophosphate) | C36H18F30N6P2Ru | 1267.54 | | |
| 14295-17-1 | | 2-chlorobenzaldehyde (4-nitrophenyl)hydrazone | | | | |
| 14295-43-3 | C.I.颜料红88 | Benzo[b]thiophen-3(2H)-one,4,7-dichloro-2-(4,7-dichloro-3-oxobenzo[b]thien-2(3H)-ylidene)- | C16H4Cl4O2S2 | | | |
| 14295-52-4 | 4-((二乙氧基磷酰基)甲基)苯甲酸甲酯 | methyl 4-((diethoxyphosphoryl)methyl)benzoate | C13H19O5P | 286.26 | | |
| 14295-64-8 | | glycerol triisobutyrate | | | | |
| 14295-72-8 | 3-(4-氯苯基)-4,5-二氢-1-[4-(甲磺酰基)苯基]-1H-吡唑 | 1H-Pyrazole,3-(4-chlorophenyl)-4,5-dihydro-1-[4-(methylsulfonyl)phenyl]- | C16H15ClN2O2S | | | |
| 142950-82-1 | | (R)-a-phenyl-1-piperidineethanamine 2hcl | | | | |
| 1429505-03-2 | Soticlestat | | C23H23N3O2 | 373.456 | | |
| 1429505-77-0 | | 4-(4-fluorobenzyl)-4-hydroxypiperidine hcl | | | | |
| 1429510-61-1 | 2-甲氧基-3,5-二甲基吡啶-4-胺 | 2-methoxy-3,5-dimethylpyridin-4-amine | C8H12N2O | 152.19 | | |
| 1429510-62-2 | | 2-fluoro-4-iodo-3,5-dimethylpyridine | C7H7FIN | 251.0401 | | |
| 1429510-79-1 | 3-溴-2-氯-5-氟-4-甲基吡啶 | 3-Bromo-2-chloro-5-fluoro-4-methylpyridine | C6H4BrClFN | 224.46 | | |
| 1429510-82-6 | 5-氨基-4,6-二甲基-2-氰基吡啶 | 5-Amino-4,6-dimethylpicolinonitrile | C8H9N3 | 147.1772 | | |
| 1429515-59-2 | FN-1501 | | C22H25N9O | 431.49 | | |
| 1429516-79-9 | n-[3,5-双(三氟甲基)苯基]-n'-[(1S,2S)-2-(二戊基氨基)环己基]硫脲 | n-[3,5-bis(trifluoromethyl)phenyl]-n'-[(1S,2S)-2-(dipentylamino)cyclohexyl]thiourea | C25H37F6N3S | 525.6 | | |
| 142955-50-8 | | boc-glycine n-carboxy anhydride | | | | |
| 142955-51-9 | | boc-phe-nca | C15H17NO5 | 291.30 | | |
| 1429551-15-4 | | 4-fluoro-3,5-dimethylcinnamic acid | | | | |
| 1429560-52-0 | (R)-1-(2,4-dimethoxybenzyl)-5-ethoxy-6-methyl-1,2,3,6-tetrahydropyrazine | | C16H24N2O3 | 292.37 | | |
| 14296-80-1 | | 1,2-bis(methylene)cyclobutane | C6H8 | 80.13 | | |
| 14296-92-5 | | n-t-boc-gly-pro | C12H20N2O5 | 272.30 | | |
| 142960-16-5 | | tyr(5,12)-lys(7)-polyphemusin i | | | | |
| 1429617-90-2 | | ddr1 inhibitor 7Rh | C30H29F3N6O | 546.59 | | |
| 1429617-95-7 | | methyl 4-ethyl-3-ethynylbenzoate | | | | |
| 1429618-03-0 | 4-乙基-3-(2-{吡唑并[1,5-a]嘧啶-6-基}乙炔基)苯甲酸 | 4-ethyl-3-(2-{pyrazolo[1,5-a]pyrimidin-6-yl}ethynyl)benzoic acid | C17H13N3O2 | 291.3 | | |
| 142962-89-8 | | 1-[2-(4-bromophenyl)ethyl]piperazine 2hcl | C14H18BrF3N2O | 367.21 | | |
| 142962-95-6 | diacetato[(s)-(-)-2,2′-bis(diphenylphosphino)-5,5′,6,6′,7,7′,8,8′-octahydro-1,1′-binaphthyl]ruthenium(ii) | (s)-ru(oac)2(h8-binap) | C44H40P2.C4H6O4Ru | 849.90 | >100°C | |
| 1429624-21-4 | (E)-N'-羟基乙脒 | (E)-N'-Hydroxyacetimidamide | C2H6N2O | 74.08 | | |
| 1429624-84-9 | | pi4kiiibeta-in-9 | C23H25N3O5S2 | 487.59 | | |
| 142963-60-8 | 伐昔洛韦ep杂质r | valaciclovir ep impurity r | | | | |
| 142963-63-1 | 伐昔洛韦ep杂质j | valaciclovir ep impurity j | | | | |
| 1429636-72-5 | 多索茶碱杂质6 | doxofylline impurity 6 | | | | |
| 1429636-74-7 | 多索茶碱杂质1 | doxofylline impurity 1 | | | | |
| 1429639-50-8 | | cz415 | C22H29N5O4S | 459.56 | | |
| 1429639-72-4 | 2,4-二氯-5H，7H-6λα-噻吩并[3,4-d]嘧啶-6,6-二酮 | 2,4-Dichloro-5H,7H-6λ⁶-thieno[3,4-d]pyrimidine-6,6-dione | C6H4Cl2N2O2S | 204.63 | | 523.4±50.0 °C(Predicted) |
m.cnreagent.com